These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28355610)

  • 1. Thymic Neuroendocrine Neoplasms: Biological Behaviour and Therapy.
    Jia R; Sulentic P; Xu JM; Grossman AB
    Neuroendocrinology; 2017; 105(2):105-114. PubMed ID: 28355610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung and Thymic Carcinoids.
    Hann CL; Forde PM
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):699-709. PubMed ID: 30098725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I-general overview.
    Oberg K; Astrup L; Eriksson B; Falkmer SE; Falkmer UG; Gustafsen J; Haglund C; Knigge U; Vatn MH; Välimäki M;
    Acta Oncol; 2004; 43(7):617-25. PubMed ID: 15545182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic neuroendocrine tumors.
    Lausi PO; Refai M; Filosso PL; Ruffini E; Oliaro A; Guerrera F; Brunelli A
    Thorac Surg Clin; 2014 Aug; 24(3):327-32. PubMed ID: 25065934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of thymic tumours.
    Srirajaskanthan R; Toubanakis C; Dusmet M; Caplin ME
    Lung Cancer; 2008 Apr; 60(1):4-13. PubMed ID: 18343528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles of thymic neuroendocrine tumors (carcinoids) with ectopic ACTH syndrome reveal novel molecular mechanism.
    Bi YF; Liu RX; Ye L; Fang H; Li XY; Wang WQ; Zhang J; Wang KK; Jiang L; Su TW; Chen ZY; Ning G
    Endocr Relat Cancer; 2009 Dec; 16(4):1273-82. PubMed ID: 19625467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
    Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
    Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiothoracic manifestations of neuroendocrine tumours.
    Mandegaran R; David S; Screaton N
    Br J Radiol; 2016; 89(1060):20150787. PubMed ID: 26781701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up.
    Oberg K; Jelic S;
    Ann Oncol; 2009 May; 20 Suppl 4():147-9. PubMed ID: 19454438
    [No Abstract]   [Full Text] [Related]  

  • 10. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.
    Habbe N; Waldmann J; Bartsch DK; Fendrich V; Rothmund M; Langer P
    Surgery; 2008 Nov; 144(5):780-5. PubMed ID: 19081021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
    Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
    Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Öberg K; Hellman P; Ferolla P; Papotti M;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii120-3. PubMed ID: 22997444
    [No Abstract]   [Full Text] [Related]  

  • 13. [Neuroendocrine neoplasms of the mediastinum].
    Brcic L; Heidinger M; Popper H
    Pathologe; 2016 Sep; 37(5):434-40. PubMed ID: 27507161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathologic Classification of Neuroendocrine Neoplasms.
    Klimstra DS
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):1-19. PubMed ID: 26614366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art.
    Tabaksblat EM; Langer SW; Knigge U; Grønbæk H; Mortensen J; Petersen RH; Federspiel BH; Ladekarl M
    Acta Oncol; 2016; 55(1):3-14. PubMed ID: 26223571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies.
    Bataller L; Valero C; Díaz R; Froufe A; Garcia-Zarza A; Ribalta T; Vilchez JJ; Saiz A
    J Neurol Neurosurg Psychiatry; 2009 Jun; 80(6):696-7. PubMed ID: 19448100
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuroendocrine tumors of the thymus.
    Ruffini E; Oliaro A; Novero D; Campisi P; Filosso PL
    Thorac Surg Clin; 2011 Feb; 21(1):13-23, v. PubMed ID: 21070983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generalised hyperpigmentation caused by ectopic adrenocorticotropic hormone syndrome with recurrent thymic neuroendocrine carcinoma.
    Moon HR; Won CH; Chang SE; Lee MW; Choi JH; Moon KC
    Australas J Dermatol; 2015 May; 56(2):131-3. PubMed ID: 25123488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Various neuroendocrine tumors in a family with multiple endocrine neoplasia type 1].
    Sepp K; Valkusz Z
    Orv Hetil; 2013 Dec; 154(51):2037-42. PubMed ID: 24334135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymic neuroendocrine tumor presenting with the ectopic ACTH syndrome.
    Barbieri JS; Seshasai R; Shemesh A; Sedrak M; Hoffman B; Alley EW
    J Thorac Oncol; 2013 Jun; 8(6):e57-8. PubMed ID: 23676563
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.